We are live on
!
Find out more
IPCP
Iron Park Capital Partners Portfolio holdings
AUM
$621K
1-Year Est. Return
73.14%
This Fund
S&P 500
This Quarter
Est. Return
-68.39%
1 Year Est. Return
-73.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$621K
AUM Growth
-$6.81M
(-92%)
Cap. Flow
-$5.46M
Cap. Flow
% of AUM
-879.67%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TriSalus Life Sciences
TLSI
|
+$5.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0% |
No holdings matched the selected filter criteria.
Similar funds
EVCM
AC
SHG
EC
RIR
FWM
SKCP
OP
Iron Park Capital Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Iron Park Capital Partners held 2 positions worth $621K, down 92% from $7.43M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Iron Park Capital Partners withdrew a net $5.46M in Q4 2022, closing 1 position. Its most notable exit was TriSalus Life Sciences, an estimated $5.46M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 0% of assets, down from 74% a quarter earlier.
- Iron Park Capital Partners fully exited TriSalus Life Sciences in Q4 2022, selling an estimated $5.46M.
- Iron Park Capital Partners's ten largest holdings make up 100% of its $621K portfolio in Q4 2022.
- Iron Park Capital Partners opened 0 new positions and closed 1 in Q4 2022.
- Iron Park Capital Partners's portfolio value fell 92% quarter-over-quarter to $621K.
Based on Iron Park Capital Partners's 13F filing for Q4 2022, filed 31 Jan 2023.